APLS

Apellis Pharmaceuticals, Inc. SEC filings

Every EDGAR filing for Apellis Pharmaceuticals, Inc. (APLS), newest first, with AI summaries and stories.

Ticker
APLS
CIK
1492422
Latest filing
Jun 5

Watch in the app Get the app

Get an email when Apellis Pharmaceuticals, Inc. files

One email per filing with the plain-English summary. Confirm once; unsubscribe in one click.

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

  1. ROUTINESCHEDULE 13G/AApellis Pharmaceuticals, Inc.APLS

    2 13G filings

    Ownership stake disclosure by Deep Track Capital, LP (amended)

    Show all 2
    • SCHEDULE 13G/AOwnership stake disclosure (amended)
    • SCHEDULE 13G/AOwnership stake disclosure (amended)

    Deep Track Capital, LP, filed by

  2. ROUTINE4Apellis Pharmaceuticals, Inc.APLS

    18 insider filings

    A. Sinclair Dunlop, insider filing for APLS

    Show all 18
    • 4Insider filing for APLS
    • 4Insider filing for APLS
    • 4Insider filing for APLS
    • 4Insider filing for APLS
    • 4Insider filing for APLS
    • 4Insider filing for APLS
    • 4Insider filing for APLS
    • 4Insider filing for APLS
    • 4Insider filing for APLS
    • 4Insider filing for APLS
    • 4Insider filing for APLS
    • 4Insider filing for APLS
    • 4Insider filing for APLS
    • 4Insider filing for APLS
    • 4Insider filing for APLS
    • 4Insider filing for APLS
    • 4Insider filing for APLS
    • 4Insider filing for APLS

    A. Sinclair Dunlop, reporting

Older filings on EDGAR